PAVmed Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
3.80
7.10
9.80
Gross Income
-
-
3.80
7.10
9.80
SG&A Expense
274.40
1,776.60
5,647.10
8,027.00
10,553.40
EBIT
274.40
1,776.60
5,650.90
8,034.10
10,563.20
Unusual Expense
-
-
-
2,363.80
4,602.20
Non Operating Income/Expense
-
-
-
3,124.30
-
Interest Expense
-
-
-
724.70
3,007.40
Pretax Income
274.40
1,776.60
5,650.90
9,519.30
18,172.80
Consolidated Net Income
274.40
1,776.60
5,650.90
9,519.30
18,172.80
Net Income
274.40
1,776.60
5,650.90
9,519.30
17,968.80
Net Income After Extraordinaries
274.40
1,776.60
5,650.90
9,519.30
17,968.80
Net Income Available to Common
274.40
1,776.60
5,650.90
10,398.10
18,750.80
EPS (Basic)
0.02
0.13
0.44
0.77
0.84
Basic Shares Outstanding
13,450.00
13,310.00
12,972.20
13,496.00
22,276.30
EPS (Diluted)
0.02
0.13
0.44
0.77
0.84
Diluted Shares Outstanding
13,450.00
13,310.00
12,972.20
13,496.00
22,276.30
EBITDA
274.40
1,776.60
5,647.10
8,027.00
10,553.40
Preferred Dividends
-
-
-
878.90
782

About PAVmed

View Profile
Address
One Grand Central Place
New York New York 10165
United States
Employees -
Website http://www.pavmed.com
Updated 07/08/2019
PAVmed, Inc. is a medical device company, which develops and commercializes a pipeline of medical products. Its product portfolio includes DisappEAR, PORTIO, Caldus, Carpx, NextCath, and NextFlo. The company was founded on June 26, 2014 and is headquartered in New York, NY.